...Nili Schamroth Pravda; Shaul Lev; Osnat Itzhaki Ben Zadok; Ran Kornowski; Zaza Iakobishvili Introduction: Patients undergoing chemotherapy are extremely vulnerable to cardiotoxicity. Early detection of cardiac dysfunction is of vital importance to optimize the management of these patients...

... dysfunction linked to anthracyclines – one of the most common conventional chemotherapies – has extensively been described and several mechanisms have been proposed, although their mode of action is not fully understood even in cancer cells. The mediation of cardiac damage by reactive oxygen species stress...

...Ga Yeon Lee; Kye Taek Ahn; Chul Won Jung; Sung-A Chang Chemotherapy-induced pericarditis has been reported in a limited number of case series. Furthermore, the management of acute pericarditis associated with chemotherapy is not standardized. In a few case reports, pericarditis associated...

... was ≥500 mg/dl. Four out of 38 evaluable patients presented hypertriglyceridemia (fig. 1 ). Hypertriglyceridemia was severe in 2 patients, with values above 1,000 mg/dl and evidence was found at the sixth and second cycles of chemotherapy, respectively (cases 1 and 2). In the 2 remaining patients...

... in the course of chemotherapy with mitoxantrone (MTX) for advanced breast cancer. Nine patients had received prior cardiotoxic treatments. Our findings indicate that patients treated with MTX may develop late potentials. 24 12 1990 19 02 1991 12 11 2008 Signal-averaged electrocardiography...